Summary
This report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and this report counts product types and end industries in global and major regions.
Market Segment as follows:
By Region / Countries
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc)
Asia-Pacific (China, India, Japan, Southeast Asia etc)
South America (Brazil, Argentina etc)
Middle East & Africa (Saudi Arabia, South Africa etc)
By Type
G-CSF
Hematopoietic Agents
Monoclonal Antibodies
By End-User / Application
Retail Pharmacies
Hospital Pharmacies
Online Pharmacies
By Company
Celltrion Inc.
Pfizer Inc.
Biocon
BIOCAD
Apotex Inc.
Dr. Reddy's
Sandoz International GmbH
Intas Pharmaceuticals Ltd.
STADA Arzneimittel AG
Teva Pharmaceutical Industries Ltd
Table of Contents
1 Market Definition
1.1 Market Segment Overview
1.2 by Type
1.3 by End-Use / Application
2 Global Market by Vendors
2.1 Market Share
2.2 Vendor Profile
2.3 Dynamic of Vendors
3 Global Market by Type
3.1 Market Share
3.2 Introduction of End-Use by Different Products
4 Global Market by End-Use / Application
4.1 Market Share
4.2 Overview of Consumption Characteristics
4.2.1 Preference Driven
4.2.2 Substitutability
4.2.3 Influence by Strategy
4.2.4 Professional Needs
5 Global Market by Regions
5.1 Market Share
5.2 Regional Market Growth
5.2.1 North America
5.2.2 Europe
5.2.3 Asia-Pacific
5.2.4 South America
5.2.5 Middle East & Africa
6 North America Market
6.1 by Type
6.2 by End-Use / Application
6.3 by Regions
7 Europe Market
7.1 by Type
7.2 by End-Use / Application
7.3 by Regions
8 Asia-Pacific Market
8.1 by Type
8.2 by End-Use / Application
8.3 by Regions
9 South America Market
9.1 by Type
9.2 by End-Use / Application
9.3 by Regions
10 Middle East & Africa Market
10.1 by Type
10.2 by End-Use / Application
10.3 by Regions
11 Market Forecast
11.1 Global Market Forecast (2018-2023)
11.2 Market Forecast by Regions (2018-2023)
11.3 Market Forecast by Type (2018-2023)
11.4 Market Forecast by End-Use / Application (2018-2023)
12 Key Manufacturers
12.1 Celltrion Inc.
12.1.2 Company Overview
12.1.2 Product and End-User / Application
12.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.2 Pfizer Inc.
12.2.1 Company Overview
12.2.2 Product and End-User / Application
12.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.3 Biocon
12.3.1 Company Overview
12.3.2 Product and End-User / Application
12.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.4 BIOCAD
12.4.1 Company Overview
12.4.2 Product and End-User / Application
12.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.5 Apotex Inc.
12.5.1 Company Overview
12.5.2 Product and End-User / Application
12.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.6 Dr. Reddy's
12.12.1 Company Overview
12.12.2 Product and End-User / Application
12.12.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.7 Sandoz International GmbH
12.7.1 Company Overview
12.7.2 Product and End-User / Application
12.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.8 Intas Pharmaceuticals Ltd.
12.8.1 Company Overview
12.8.2 Product and End-User / Application
12.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.9 STADA Arzneimittel AG
12.9.1 Company Overview
12.9.2 Product and End-User / Application
12.9.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.10 Teva Pharmaceutical Industries Ltd
12.10.1 Company Overview
12.10.2 Product and End-User / Application
12.10.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
9 Research Conclusion
List Of Tables
Table Global Oncology Biosimilars Market and Growth by Type
Table Global Oncology Biosimilars Market and Growth by End-Use / Application
Table Global Oncology Biosimilars Revenue (Million USD) by Vendors (2015-2017)
Table Global Healthcare & Medical Revenue Share by Vendors (2015-2017)
Table Global Oncology Biosimilars Market Volume (Volume) by Vendors (2015-2017)
Table Global Oncology Biosimilars Market Volume Share by Vendors (2015-2017)
Table Headquarter, Factories & Sales Regions Comparison of Vendors
Table Product List of Vendors
Table Global Oncology Biosimilars Market (Million USD) by Type (2015-2017)
Table Global Oncology Biosimilars Market Share by Type (2015-2017)
Table Global Oncology Biosimilars Market Volume (Volume) by Type (2015-2017)
Table Global Oncology Biosimilars Market Volume Share by Type (2015-2017)
Table Global Oncology Biosimilars Market (Million USD) by End-Use / Application (2015-2017)
Table Global Oncology Biosimilars Market Share by End-Use / Application (2015-2017)
Table Global Oncology Biosimilars Market Volume (Volume) by End-Use / Application (2015-2017)
Table Global Oncology Biosimilars Market Volume Share by End-Use / Application (2015-2017)
Table Global Oncology Biosimilars Market (Million USD) by Regions (2015-2017)
Table Global Oncology Biosimilars Market Share by Regions (2015-2017)
Table Global Oncology Biosimilars Market Volume (Volume) by Regions (2015-2017)
Table Global Oncology Biosimilars Market Volume Share by Regions (2015-2017)
Table North America Oncology Biosimilars Market (Million USD) by Type (2015-2017)
Table North America Oncology Biosimilars Market Share by Type (2015-2017)
Table North America Oncology Biosimilars Market (Million USD) by End-Use / Application (2015-2017)
Table North America Oncology Biosimilars Market Share by End-Use / Application (2015-2017)
Table North America Oncology Biosimilars Market (Million USD) by Regions (2015-2017)
Table North America Oncology Biosimilars Market Share by Regions (2015-2017)
Table Europe Oncology Biosimilars Market (Million USD) by Type (2015-2017)
Table Europe Oncology Biosimilars Market Share by Type (2015-2017)
Table Europe Oncology Biosimilars Market (Million USD) by End-Use / Application (2015-2017)
Table Europe Oncology Biosimilars Market Share by End-Use / Application (2015-2017)
Table Europe Oncology Biosimilars Market (Million USD) by Regions (2015-2017)
Table Europe Oncology Biosimilars Market Share by Regions (2015-2017)
Table Asia-Pacific Oncology Biosimilars Market (Million USD) by Type (2015-2017)
Table Asia-Pacific Oncology Biosimilars Market Share by Type (2015-2017)
Table Asia-Pacific Oncology Biosimilars Market (Million USD) by End-Use / Application (2015-2017)
Table Asia-Pacific Oncology Biosimilars Market Share by End-Use / Application (2015-2017)
Table Asia-Pacific Oncology Biosimilars Market (Million USD) by Regions (2015-2017)
Table Asia-Pacific Oncology Biosimilars Market Share by Regions (2015-2017)
Table South America Oncology Biosimilars Market (Million USD) by Type (2015-2017)
Table South America Oncology Biosimilars Market Share by Type (2015-2017)
Table South America Oncology Biosimilars Market (Million USD) by End-Use / Application (2015-2017)
Table South America Oncology Biosimilars Market Share by End-Use / Application (2015-2017)
Table South America Oncology Biosimilars Market (Million USD) by Regions (2015-2017)
Table Middle East & Africa Oncology Biosimilars Market Share by Regions (2015-2017)
Table Middle East & Africa Oncology Biosimilars Market (Million USD) by Type (2015-2017)
Table Middle East & Africa Oncology Biosimilars Market Share by Type (2015-2017)
Table Middle East & Africa Oncology Biosimilars Market (Million USD) by End-Use / Application (2015-2017)
Table Middle East & Africa Oncology Biosimilars Market Share by End-Use / Application (2015-2017)
Table Middle East & Africa Oncology Biosimilars Market (Million USD) by Regions (2015-2017)
Table Middle East & Africa Oncology Biosimilars Market Share by Regions (2015-2017)
Table Global Oncology Biosimilars Market (Million USD) Forecast by Regions (2018-2023)
Table Global Oncology Biosimilars Market Share Forecast by Regions (2018-2023)
Table Global Oncology Biosimilars Market Volume (Volume) Forecast by Regions (2018-2023)
Table Global Oncology Biosimilars Market Volume Share Forecast by Regions (2018-2023)
Table Global Oncology Biosimilars Market (Million USD) Forecast by Type (2018-2023)
Table Global Oncology BiosimilarsMarket Share by Forecast Type (2018-2023)
Table Global Oncology Biosimilars Market (Million USD) Forecast by End-Use / Application (2018-2023)
Table Global Oncology Biosimilars Market Share Forecast by End-Use / Application (2018-2023)
Table Sales Revenue, Volume, Price, Cost and Margin of Celltrion Inc.
Table Sales Revenue, Volume, Price, Cost and Margin of Pfizer Inc.
Table Sales Revenue, Volume, Price, Cost and Margin of Biocon
Table Sales Revenue, Volume, Price, Cost and Margin of BIOCAD
Table Sales Revenue, Volume, Price, Cost and Margin of Apotex Inc.
Table Sales Revenue, Volume, Price, Cost and Margin of Dr. Reddy's
Table Sales Revenue, Volume, Price, Cost and Margin of Sandoz International GmbH
Table Sales Revenue, Volume, Price, Cost and Margin of Intas Pharmaceuticals Ltd.
Table Sales Revenue, Volume, Price, Cost and Margin of STADA Arzneimittel AG
Table Sales Revenue, Volume, Price, Cost and Margin of Teva Pharmaceutical Industries Ltd
Published Date: Aug 2017
List Of Figures
Figure Global Oncology Biosimilars Market Size (Million USD) 2012-2022
Figure North America Market Growth 2015-2018
Figure Europe Market Growth 2015-2017
Figure Asia-Pacific Market Growth 2015-2017
Figure South America Market Growth 2015-2017
Figure Middle East & Africa Market Growth 2015-2017
Figure Global Oncology Biosimilars Market (Million USD) and Growth Forecast (2018-2023)
Figure Global Oncology Biosimilars Market Volume (Volume) and Growth Forecast (2018-2023)
